Company Data

Trevena Inc.

Advanced Market Data

Ticker

TRVN

Current Price

$0.9896

Market Cap

$854.8K

Price Target

Refer to Report

Volume

6

52wk Range

$0.7253 - $7.85

Advanced Market Data

Overview

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Other Considerations

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Nutriband Inc.

NTRB (NSC)

$8.115

$8.2(-1.04%)

90.5M

11.5K

$3.7223 - $11.78

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Unicycive Therapeutics Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc.

UNCY (NSC)

$5.215

$5.25(-0.67%)

62.9M

105.8K

$2.02 - $11

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Cadrenal Therapeutics Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc.

CVKD (NSC)

$12.9898

$13(-0.08%)

25.5M

8.2K

$5.7 - $22.9011

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

LakeShore Biopharma Co. Ltd.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

LakeShore Biopharma Co. Ltd.

LakeShore Biopharma Co. Ltd.

LSB (NSC)

$1.12

$1.07(4.67%)

21.4M

59.3K

$0.87 - $8.6

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

MAIA Biotechnology Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

MAIA Biotechnology Inc.

MAIA Biotechnology Inc.

MAIA (AMX)

$1.8968

$1.93(-1.72%)

57.5M

89.2K

$1.4 - $4.24

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Baudax Bio Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Baudax Bio Inc.

Baudax Bio Inc.

BXRX (Nasdaq)

109.6K

$0.0137 - $3.4699

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Eledon Pharmaceuticals

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Eledon Pharmaceuticals

Eledon Pharmaceuticals

ELDN (Nasdaq)

$3.395

$3.45(-1.59%)

203.3M

9.8K

$2.375 - $5.54

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Tonix Pharmaceuticals Holding Corp.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.

TNXP (Nasdaq)

$40.56

$42.36(-4.25%)

297.1M

143.0K

$6.76 - $130

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Ocugen, Inc.

OCGN (Nasdaq)

$1.15

335.8M

1.4M

$0.515 - $1.979

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

PDS Biotechnology Corporation

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

PDS Biotechnology Corporation

PDS Biotechnology Corporation

PDSB (Nasdaq)

$1.2708

$1.3(-2.25%)

58.1M

133.8K

$0.8505 - $4.42

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data